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Minor histocompatibility (H) 1 antigens are non-H-2 transplantation antigens, of 
which  ~40  have  been  identified  (1).  A  vigorous  cytotoxic T  lymphocyte  (CTL) 
response to minor H  antigens requires in vivo priming, and CTL so generated are H- 
2 restricted in their activity (2, 3).  Priming for minor H  antigens generally involves 
injection of ~107  viable  spleen  cells.  Induction of CTL  by  in  vivo  priming with 
lymphoid cells appears to follow several pathways, some of which are diagrammed 
schematically in  Fig.  1.  We  have  previously shown  that  some  component  of the 
antigen-bearing spleen cell population is competent to present minor H  antigens to 
CTL precursors directly (4). Recipient cells also appear capable of presenting injected 
minor H  antigens, as evidenced by the phenomenon of cross-priming, which refers to 
the finding that  (A  ×  B)F1 mice injected with H-2  A minor-H-different spleen cells 
(A')  will generate not only H-2  A- but also H-2B-restricted CTL activity (5). In our 
view, the most experimentally sound explanation for cross-priming is that antigen- 
presenting cells in an (A ×  B)F1 animal injected with A' spleen cells can reprocess and 
present these minor H  antigens in conjunction with both H-2 A and H-2  B (4, 6, 7). 
Consistent with that view, it seemed likely that a kinetic study of F1 mice injected 
with A' cells would reveal early direct priming to minor H  plus-H-2  A followed later, 
after antigen reprocessing, by cross-priming to minor H-plus-H-2  B. To our surprise, 
3-6  d  after antigen injection the minor H-specifc, H-2A-restricted CTL response in 
such animals is severely depressed relative to the minor H-plus-H-2  B and third-party 
alloreactive responses. Experiments described below were designed to investigate the 
nature of this haplotype-specific CTL hyporeactivity. 
Materials and Methods 
Mice.  C57B1/10Sn (B10, H-2b), B10.D2nSn (H-2d), B10.BrSgSn (H-2k), and (AKR/J × 
DBA/2J)F1 [(AKD2)F1, H-2k/H-2 d] mice were purchased  from The Jackson Laboratory, Bar 
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Harbor,  ME. The following strains of mice were bred  in our animal facilities at  the Stanford 
University Medical Center: A.TH (H-2KTDa), A.TL (H-2KSIkDa), BALB/c (C, H-2d), BALB.B 
(C.B, H-2b), BALB.K (C.K, H-2k), and the various BALB and C57B[ F1  mice. [Parent ~  F1] 
chimeras were prepared  by  injecting T  cell-depleted parental  bone  marrow  into F~  animals 
that  had previously received 1,000 rad from a  137Cs source (4). 
Antisera and Monoclonal Antibodies.  The A.TH anti-A.TL antiserum  (anti-I  k) was prepared by 
multiple intraperitoneal injections with spleen cells and screened for specific cytotoxicity against 
lymphoid cells from congenic strains of mice. The monoclonal anti-Thy-l.2  reagent  13-4  was 
prepared as previously described (8). T24/31.7  (T24)  is a  rat-mouse hybridoma that secretes a 
monoclonal antibody that recognizes a  mouse-specific determinant on Thy-1  (9).  AD4(15)  is a 
monoclonal  antibody  that  recognizes Lyt-2.2  (10).  Rabbit  anti-mouse  immunoglobulin  was 
prepared by multiple injections with purified mouse IgG in complete Freund's adjuvant. The 
(Fab')2 reagents used for plate separation were prepared by N. Landau, Massachusetts Institute 
of Technology, Cambridge, MA. 
Mixed  Lymphocyte Culture (MLC)  and Cytotoxicity Assay.  Spleen  or  lymph  node  cells  from 
responder  animals  were  cultured  as  previously  described  (11)  with  an  equal  number  of 
irradiated  (1,000 tad)  stimulator cells of the specified type. Trinitrophenyl  (TNP)  modificaton 
was  performed  according  to  Shearer  (12).  After  5  d  of MLC,  serial  threefold  dilutions  of 
responder  cells were  added  to  4  ×  104  ~lCr-labeled  target  cells in  a  total  vol of  1 ml.  The 
percent specific lysis after 4 h  of incubation was calculated in the following manner: 
(counts per minute released by responders 
-  counts per minute released by medium alone) 
X  100. 
(counts per minute released by detergent 
-  counts per minute released by medium alone) 
Target cells were spleen cells which had been cultured for 2 d with concanavalin A  (Con A) 
as previously described (3). 
Lymphoid Cell Subpopulations.  Cells to be treated with antiserum were resuspended at  107/ml 
in an asppropriate dilution of antibody,  incubated  for 30 min at 4°C, washed,  resuspended  at 
5  X  10/ml  in a  selected rabbit  serum,  and  incubated  for 45  rain  at  37°C.  The  dilutions  of 
antibodies used were predetermined to kill plateau levels of the appropriate ceils. 
Purified T  cells were obtained from spleen and lymph node cells nonadherent  to Petri dishes 
coated with rabbit  anti-mouse immunoglobulin, according to previously described techniques 
(13,  14). Selection  on  the  basis  of adherence  to  anti-Lyt-2.2-  [AD4(15)]  coated  plates  were 
performed  in a  similar manner.  The efficacy of each separation  was  assessed  by typing StCr- 
labeled  cells  with  anti-Thy-1,  anti-Lyt-2,  anti-Ia,  and  anti-H-2  sera  plus  complement  (C). 
NyIon wool column enrichment of T  cells was performed exactly as described previously (I5). 
host CTL 
injected A'  precursors 
host presenting cell 
Fro.  1.  Minor-H-different (A') spleen cells are injected into an (A X B)F1 recipient. Although the 
anti-A' CTL precursors  can recognize  minor H  antigens on both the injected cells and  on host 
antigen-presenting cells, host CTL precursors specific for B' are activated by F1 host cells presenting 
the injected minor H antigens.  Recognition of antigen directly on the A' cells may lead to temporary 
inactivation. PAMELA FINK, IRVING WEISSMAN, AND MICHAEL BEVAN  143 
Results 
Haplotype-specific  Suppression  of CTL  Response  to  Minor H  Antigens.  To  study  the 
kinetics of direct- vs. cross-priming of minor H-specific CTL, (C.K ×  C)F1 (H-2  k ×  H- 
2  d) mice were injected intravenously with  12 ×  106 viable B10.Br (H-2  k) spleen cells. 
We expected the in vivo expansion of CTL involved in the direct-primed response 
(anti-B10.Br)  to appear early, activated by presentation of minor H  antigens-plus- 
H-2 on the injected spleen cells themselves (Fig.  1; reference 4), whereas we expected 
the appearance of the cross-primed CTL response (anti-B 10.D2) to follow, activated 
by minor H  antigens processed by host Fa antigen-presenting cells (4, 7). To assay the 
results of such in vivo priming, responder spleens were removed 4-10 d after antigen 
injection and cultured for 5 d with irradiated (BI0.Br ×  B10.D2)F1 stimulators that 
provide further in vitro stimulation of both the direct primed and the cross-primed 
CTL. Separate stimulation with B10.Br or B10.D2 cells does not activate both CTL 
populations, as cross-boosting of CTL to minor H  antigens does not occur in vitro 
during a 5-d secondary MLC (3). Data representative of several such experiments are 
shown  in  Table I  and  demonstrate, surprisingly,  that  the cross-primed response is 
significantly greater than  the  direct-primed  response early after priming.  In  most 
cases, the level of cross-primed CTL activity is invariant from days 5-10 postinjection, 
whereas  the  direct-primed  response  increases  sharply  during  this  time.  Both  the 
severity and the duration of the hypoactivity of the direct primed response are directly 
related to the dose of injected B10.Br cells, and  this hypoactivity is not  evident in 
animals injected with B10.Br cells that have been irradiated with 1,000 rad (Table I). 
Full titration curves for the 51Cr-release assay from a single experiment are shown 
in Fig. 2. Fig. 2 A and B show the haplotype-specific hypoactivity of the direct-primed 
response; Fig. 2 C is a positive control to show that (C.K ×  C)F1 hosts develop similar 
levels of CTL activity to minor H  antigens on B10.Br and B10.D2 Con A  blasts if 
primed with  (B10.Br ×  B10.D2)F1 spleen cells some weeks before in vitro boosting. 
Priming Fx hosts with minor-H-different Fa cells prevents the later induction of direct- 
primed hypoactivity, although  it  is  not  known whether this  is  a  quantitative or a 
qualitative effect (data not shown). 
The cross-primed response presumably results from the activation of CTL by F1 
antigen-presenting cells, which should also activate the anti-B 10.Br CTL, suggesting 
that injection of viable B 10.Br spleen cells leads to a specific "depletion" or suppression 
of anti-B10.Br CTL. That the skewed ratio of the direct- and cross-primed responses 
results from a depression of the direct response rather than from a heightened cross- 
primed response is also demonstrated by priming with irradiated B 10.Br cells (Table 
I). In this case, equally high levels of direct- and cross-primed responses appear early 
after priming. 
Direct-primed CTL activity can be suppressed  by injection of minor H  different 
cells of both parental haplotypes in all strains of mice we have tested, including (C.K 
×  C)F1  and  (AKD2)F1 mice injected with  B10.Br and  B10.D2,  (C  ×  C.B)F1  mice 
injected with B10 and B10.D2, and (B10 ×  B10.D2)F1 mice injected with C and C.B 
(data not shown). 
Suppression of CTL activity is clearly haplotype specific (H-2  k spleen cells deplete 
only H-2k-restricted CTL) and is antigen specific (animals depleted for anti-B10.Br 
activity can  still  mount  a  good CTL response to TNP plus  H-2  k,  Table I).  Thus, 
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TABLE  I 
Kinetics of Anttgen- and Haplotype-specific Depletion of CTL Response by Injected 
Antigen 
Percent specific lysis 
Day of  of target cells:[:  Ratio of 
Injected spleen cells*  injection  activity§ 
B10.Br  BI0.D2 
None 
12 X l0  s B10.Br 
-2  -1 
-4  9  54  1:25 
-5  25  68  1:15 
-6  50  78  1:7 
-8  55  35  4:1 
-I0  72  68  1:1 
60 ×  l0  s BI0.Br  -6  1  39  <1:60 
--8  4  66  < 1:60 
-4 
-6 
60 X  l06 1,000 rad B10.Br 
15 x  106 (B10.Br X B10.D2)F111  --30 
25 ×  106 B10.Br  -6 
52  60  1:1 
62  59  1  : 1 
C.K-TNP  C-TNP 
54  44  3:1 
42  34  2:1 
* (C.K × C)F1 animals were injected intravenously with the indicated spleen cells. 4- 
10  d  after antigen  injection,  responder spleen  cells were  cultured  for  5  d  with 
irradiated (B10.Br ×  BI0.D2)FI  or TNP  (C.K X C)F1 stimulators.  CTL activity 
was  measured on  ~lCr-labeled  B10.Br, B10.D2,  C.K-TNP, C-TNP,  and  (C.K  × 
C)F1 Con A blasts. Spontaneous release from all targets was 16-23%. No syngeneic 
killing was mediated by any responders. 
:~ Data for an effector to target ratio of 50:1. 
§ Ratio of activity on first target to activity on second target. For example, ratio of 
anti-B 10.Br:anti-B 10.D2 CTL activity is equal to the effector to target ratio required 
to mediate a  given  level of lysis of B10.D2  targets to the effector to target ratio 
required to mediate the same level of lysis on B 10.Br. Calculated from a complete 
titration of responders against a constant number of target cells. 
II Separate aliquots of responders were boosted with (B 10.Br × B 10.D2) FI stimulators. 
A 50:1 effector to target ratio of responders from FI injected animals generated 74% 
lysis of B10.Br  and  76%  lysis of B10.D2 targets  (ratio  of activity  1:1), whereas 
B10.Br-injected  animals  generated 30%  anti-Bl0.Br and  80%  anti-B10.D2  CTL 
activity (ratio of activity  1:25). 
leads to a  severe, short-lived, haplotype and minor-H-antigen-specific suppression of 
CTL  activity. 
Suppression of Minor-H-specific  CTL  by Spleen Cell Subpopulations.  By  priming  with 
spleen cells that had been separated by various means, we hoped to identify the cell 
types  responsible for this  haplotype-specific depletion of CTL  activity.  Spleen cells 
pretreated  with  anti-Ia  serum  plus  C  were  able  to  suppress the  induction  of CTL 
more efficiently on a  per cell basis than whole spleen cells as calculated from titration 
curves, a  single point of which is shown in Table  II.  Depletion was also mediated by 
lymph node cells that were passed through nylon wool columns and then treated with 
anti-Ia  plus  C  and  were judged  free  of B  cells  and  accessory cells  by  the  loss  of 
responsiveness  to  the  mitogens  lipopolysaccharide  and  Con  A  (data  not  shown). PAMELA  FINK,  IRVING  WEISSMAN,  AND  MICHAEL  BEVAN  145 
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Flo.  2.  In vivo injection of minor-H-different H-2 homozygous cells depletes direct-primary CTL 
activity in F1 mice. (C.K ×  C)F1  (H-2  k ×  H-2  d) mice were injected intravenously with (A) 25 ×  t06 
BI0.Br (H-2  k) spleen ceils on day --6, (B) 25 ×  106 B10.D2 (H-2  a) spleen cells on day -6, or ((3) 15 
×  10  e (B 10.Br ×  B 10.D2)Fx spleen cells on day -2l. On day 0, spleen ceils from recipient mice were 
cultured with irradiated (C.K ×  B10.D2)F1  stimulator cells for 5 d. CTL activity was measured on 
Con A blasts of the following types: B10.Br (O), B10.D2  (A), and (C.K ×  C)F1  (l'q). Spontaneous 
release ranged from  17-22%.  Responder cell populations were also cultured with allogeneic H-2- 
different stimulator cells, and all generated comparable alloreactive CTL activity. 
Spleen cells were also pretreated with monoclonal anti-Thy-1 reagents (T24 and  13- 
4) or monoclonal anti-Lyt-2.2 lAD4(15)] plus C. In three separate experiments, Thy- 
1-negative spleen cells suppressed CTL responses from 30- to >50-fold less efficiently 
on a per cell basis than cells treated with C alone. High doses of cells pretreated with 
anti-Lyt-2 plus C were still able to deplete the appropriate CTL responses (Table II). 
To determine the relative efficiency of suppression  by Lyt-2-positive and  Lyt-2- 
negative T  cells, T  cells selected as nonadherent to plastic dishes coated with rabbit 
anti-mouse  immunoglobulin were separated  into Lyt-2-positive and  Lyt-2-negative 
cells on the basis of adherence to anti-Lyt-2.2-coated dishes. This latter separation is 
quite clean, as judged by antiserum typing of 51Cr-labeled separated cell populations 
(Table II). In two experiments, we assayed the ability of 3 X  106-75 ×  106 separated 
spleen cells to suppress a CTL response specifically. As illustrated in Table II, Thy-1- 
positive cells are potent depleters, and both Lyt-2-positive and Lyt-2-negative T  cells 
deplete, although Lyt-2 positive cells are 3-10-fold more efficient. As few as 3 X  106 
Lyt-2-positive T  cells mediate a  20-fold relative reduction in the direct-primed CTL 
response. 
These data allow us to conclude that the cell type(s) responsible for suppression is 
radiosensitive,  Ia-negative,  nylon  wool  nonadherent,  and  Thy-1  positive,  and  is 
therefore a T cell. Suppression can be mediated both by T  cells judged Lyt-2-positive 
by  cytotoxicity and  by  adherence  to  anti-Lyt-2-coated  plates,  and  those judged 
negative, although fewer Lyt-2-positive T  cells are required to mediate a given level 
of depletion. 
Suppression by Tolerant Spleen Cells.  The realization that T  cells are responsible for 
the suppression of the CTL response made it imperative to test whether this haplotype- 
specific depletion can be ascribed to a graft vs. host reaction on the part of the injected 
cells.  It is important to point out that we can detect no CTL activity directed against 
host  H-2  antigens  at  any  time  after  injection  of homozygous cells.  Furthermore, 146  SUPPRESSION  OF  CYTOTOXIC  T  CELL  INDUCTION 
TABLE  II 
Depletion of CTL Response by Spleen Cell Subpopulations 
Percent specific 
Day of  lysis of target cells~:  Ratio of 
Injected B10.Br spleen cells*  injection  activity~ 
BI0.Br  B10.D2 
1.  15 ×  106 untreated  --14  50  42  3:1 
75 X  106 C treated  -6  4  58  <1:80 
12 ×  l0  n anti-la +  C treated§  -6  [ 1  6I  <1:40 
75 ×  10  a anti-Thy-1 +  C treated  -6  30  40  1:2 
75 ×  106 anti-Lyt-2 +  C treated  -6  18  55  1:20 
2.  15 ×  106 unseparated  -14  61  64  1:1 
30 ×  10  ~ unseparated  -6  8  70  < 1:80 
10 ×  106 T cells[I  -6  20  71  1:50 
30 X 106 T cells  -6  5  63  <1:80 
3.3 ×  t06 Lyt-2  + T cells  -6  25  72  1:20 
10 ×  106 Lyt-2  + T cells  -6  1  78  < l:100 
10 ×  106 Lyt-2- T cells  -6  32  70  1:15 
30 X 106 Lyt-2- T cells  -6  26  75  1:25 
60 ×  10  ~ Lyt-2- T cells  -6  6  63  <1:80 
* (C.K x  C)F1 mice were injected intravenously with the indicated spleen cells. 6-14 
d after antigen injection, responder spleen cells were cultured for 5 d with irradiated 
(B10.Br  ×  B10.D2)Fx  spleen cells  and assayed for cytotoxic activity.  No  lysis of 
syngeneic (C.K ×  C)FI targets was detected. Two separate experiments are shown. 
:~ As in Table I. 
§ Spleen cells  were  treated with A.TH  anti-A.TL  (anti-I  k)  antiserum,  monoclonal 
anti-Thy-1  reagents (13-4 and T24), or monoclonal anti-Lyt-2.2 lAD4(15)]  +  C. 
Doses represent actual number of recovered cells injected. 
II "T cells" were nonadherent to plastic dishes coated with rabbit anti-mouse-immu- 
noglobulin and were found to be 75% Thy-1 +, 38% Lyt-2  + as assayed by antiserum 
+  C  treatment. Cells were further separated into Lyt-2  + and Lyt-2- fractions on 
dishes coated with AD4(15).  Lyt-2+  cells  were  100% Thy-1 +,  96% Lyt-2  +.  Lyt-2- 
cells were 78% Thy-i +, 1% Lyt-2  +. 
preimmunization  of the spleen cell donors with recipient spleen cells does not enhance 
their ability to  suppress  as judged  from  a  comparison  of the number  of normal  and 
immune  cells  able  to  mediate  a  given  level  of depletion  (data  not  shown).  These 
results  argue  against  the  dependence  of depletion  on  an  anti-H-2  or  an  anti-[host 
receptor idiotype] response by the injected cells. More definitively, suppression can be 
mediated  both  by  spleen  cells  from  [P---~F1]  chimeras  and  cells  from  animals  fully 
tolerant  to  recipient  H-2  and  minor  H  antigens  (Table  III).  For  example,  B10.D2 
cells  from  a  [B10.D2---)(B10  X  B10.D2)F1]  chimera  are  tolerant  of  H-2 b,  but  still 
deplete  H-2a-restricted  CTL  activity  from  an  F~  mouse  as  efficiently  as  do  normal 
B10.D2 spleen cells. In addition,  (C.K  ×  B10.Br)F1 ceils can suppress the anti-B10.Br 
activity  from  C.K  mice  to  the  same  extent  as  can  B10.Br  cells.  With  homozygous 
mice as responders,  the priming  with H-2  syngeneic cells follows the same kinetics as 
the direct-primed  response  in F1  responders,  i.e.,  much  slower than  the cross-primed 
response.  However,  in  the  case  of  homozygous  recipients,  the  depleted  minor  H 
antigen  response  must  be compared  with  an  alloreactive  control  instead  of with  an 
unaffected minor  H  response as is possible in F1 mice  (Table III). 
We  therefore conclude  that  no immunological  recognition of the recipient  animal 
by the injected cells is necessary for suppression of CTL  activity. These results suggest PAMELA FINK, IRVING  WEISSMAN, AND MICHAEL  BEVAN 
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Recipient* 
Percent specific lysis 
Day of  of target cells:~  Ratio of 
Injected spleen cells  injection  activity§ 
B10.Br  B10.D2 
C.K 
C 
(C x C.B)F1 
25 X 106 (C.K × B10.Br)Fx  -30  38  36  t:l 
50 x  106 B10.Br  -6  4  70  <1:200 
50 X 106 (C.K x B10.Br)F1  -6  0  70  <1:200 
25 ×  106 (C × BI0.D2)Fa  -37  75  83  1:2 
30 ×  106 B10.D2  -6  73  47  12:1 
30 X 106 (C X B10.D2)FI  -6  72  45  10:1 
B10  B10.D2 
15 X 106 (B10 × B10.D2)F~  -21  5  75  l:2 
45 x  10  ~ B10.D2  -6  61  23  20:1 
45 ×  10  6 [B10.D2---eF1] chimera  -6  66  16  50:1 
* Mice were injected intravenously with the indicated spleen cells 6-37 d before killing. Chimeras were 
constructed as described in Materials and Methods. C.K responder cells were cultured with B10.Br 
(minor H different) or B 10.D2 (allogeneic)  stimulators. C responders were cultured with B  10.D2 (minor 
H different) or B10.Br (allogeneic) stimulator spleen cells. (C × C.B)F1 responder cells were cultured 
with (B 10 × B 10.D2)FI minor H-different stimulator cells. After 5 d of MLG, CTL activity was measured 
against the indicated SlCr-labeled Con A blasts. No lysis of syngeneic targets was detected for any 
responder cell population. 
I: Data for an effector to target ratio of 50:1. 
§ Ratio of activity on first target to activity on second target. Calculated from a complete titration  of 
responders against a constant numer of target cells. 
very strongly that the specificity of the reduction in CTL activity resides in the one- 
way recognition of the injected cells by the host CTL precursors. 
Attempts to Recover Direct-Primed  CTL Activity.  It is possible that direct-primed CTL 
are present in the host during the first 6 d  of priming, but that they have localized to 
extra splenic lymphoid organs because of some antigen-dependent changes in their 
patterns of recirculation (16). However, this does not seem to be the case, as responder 
cells taken from lymph nodes of normal as well as splenectomized mice show the same 
pattern of suppression and recovery of the direct-primed CTL response as do spleen 
cell responders (Table IV). It is also possible that CTL activated by direct presentation 
of antigen by the injected cells are lost during the spleen cell preparation because of 
a  heightened sensitivity to mechanical stress, a  phenomenon that has some precedent 
(17). However, the extent of suppression is comparable from cultures of diced splenic 
fragments and of cell suspensions from the same animal (Table IV). Furthermore, in 
vivo-induced depletion cannot easily be reversed in vitro--reboosting cultures of cells 
that  are suppressed  for the direct-primed response at  day 5  of MLC  does not alter 
their  reactivity profile  (Table IV).  Thus,  if suppression is  a  result  of a  temporary 
block to antigen activation on the part of direct-primed CTL, these CTL cannot be 
rescued from their inactive state by reboosting in vitro. 
Depletion In Vitro.  We have mixed spleen cells from animals primed to F1 cells with 
those from mice injected 6  d  previously with homozygous spleen cells in an effort to 
demonstrate  whether  depletion  involves an  active  suppression  that  can  alter  the 
activity of pre-primed CTL in vitro. As shown in Table V, we found no evidence for 148  SUPPRESSION  OF  CYTOTOXIC  T  CELL  INDUCTION 
TABLE  IV 
Direct-Primed Activity  Cannot be Recovered at the Time of Suppression 
Responding  Day of  Ratio of 
Experiment  cells*  injection  activity~: 
1  Spleen  -5  1:200 
Lymph node  - 5  1  : 130 
Spleen  -6  1:50 
Lymph node  -6  1:27 
2  LN normal  -6  1:20 
LN splenecto-  -6  1:27 
mized 
3  Spleen suspension  -6  1:30 
Diced spleen  -6  1:50 
Spleen 2 °  -5  1:20 
Spleen 3 °  -5  1:15 
Spleen 2 °  -6  1:12 
Spleen 3 °  -6  1:10 
* In experiment  1, spleen and lymph node (LN)  cells were taken from the same (C 
× C.B)F1 animal injected intraperitoneally with 15 ×  108 B 10 spleen cells. Responder 
cells were boosted with irradiated (B10 ×  B10.D2)FI  cells. In experiment 2, lymph 
nodes were taken from normal (C.K × C)F1 or from mice that had been splenectom- 
ized 5 wk previously.  Both groups had been injected intravenously with 20 ×  106 
B10.Br  spleen  cells  and  boosted  in  vitro  with  (B10.Br  ×  B10.D2)F1  cells.  In 
experiment 3, one-half of a spleen from a  (C.K ×  C)F1 injected intravenously with 
25 ×  10  e B10.Br spleen cells  was teased and the other one-half diced into small 
fragments with a  scalpel.  The cell  suspension and the fragments were separately 
cultured with irradiated (B10.Br  ×  B10.D2)F1 stimulators. In experiment 4, spleen 
cells  from  (C.K  ×  C)F1 animals injected with  12  x  106 B10.Br spleen cells  were 
boosted for 5 d with irradiated (C ×  B10.Br)F1 cells. Some of the responders were 
assayed for CTL activity (2 °)  and some were reboosted on day  11 of culture and 
assayed on day 4 of reboosting (3°). 
:~ Ratio of activity on targets of the injected type to targets of the other haplotype. 
For experiment 1, it is the ratio of killing on B 10 to B 10.D2, and for experiments 2- 
4, it is the ratio of killing on B10.Br to B10.D2.  In each experiment, a full titration 
of responders was performed; control animals primed at least 2 wk previously were 
always  included.  No  significant killing on  syngeneic  targets  was  found  in  any 
experiment. 
suppression  of CTL  activity  of the  F1  primed  cells.  Thus,  spleen  cells  from  (C.K  X 
C)F1 mice recently injected with B10.Br cells cocultured  in a  4:1,  2:1,  I: 1, or  1:2 ratio 
with spleen cells from long-term primed  mice do not suppress the anti-B 10.Br response 
of  the  latter  population.  Similar  results  are  obtained  with  mixtures  of  cells  from 
animals  injected 6  d  previously  with homozygous  cells  (Table  V).  Therefore,  haplo- 
type-specific depletion is not maintained  during the period of MLC  by a  demonstrable 
suppressor  mechanism.  Experiments  to  test  for  suppression  in  vivo  (by  adoptive 
transfer, for example)  are not possible because of the short time span of the depletion. 
Discussion 
Our  experiments  show  that  the  injection  of (A')  T  cells  into  (A  ×  B)F1  animals 
results  in  the temporary  inactivation  of the CTL  specific  for  the injected cells.  This 
loss  of CTL  activity  could,  in  principle,  be  caused  by  either  direct  inactivation  of PAMELA FINK,  IRVING WEISSMAN, AND MICHAEL BEVAN  149 
TABLE  V 
Lack of ln Vitro Suppression by Depleted Populations 
Percent specific lysis of 
Responding cells*  target cells:~  Ratio of activ- 
ity§ 
BI0.Br  B10.D2 
A.  day -6 B10.Br primed  10  48  1:30 
B.  day -6 B 10.D2 primed  42  -2  >100:1 
C.  day -30 Fx primed  62  70  1:1 
Mix of A and C in the ratios 
4:1  32  52  1:4 
2:1  36  50  1:3 
1:1  38  48  1:2 
1:2  51  56  1:i 
Mix of B and C in the ratios 
4:1  44  18  9:1 
2:1  44  32  5:1 
1:1  54  50  3:1 
1:2  56  52  2:1 
Mix ofAand B in the ratios 
2:1  25  52  1:12 
1:1  54  45  2:1 
1:2  58  20  25:1 
* (C.K  ×  C)F1 mice were injected intravenously with:  A, 35  ×  10  e B10.Br 
spleen cells on day -6; B, 35 X  l0  s B10.D2 spleen cells on day -6; or C, 15 
×  106 (B10.Br ×  B10.D2)F1 spleen  ceils on day -30. On day 0, responder 
spleen cells were cultured with irradiated (B10.Br ×  B10.D2)F1 spleen cells 
for  5  d.  Responders were cells  from A,  B,  and  C  alone,  or mixtures, all 
totaling the same number of cells cultured. Cytotoxic activity was measured 
on 51Cr-labeled B 10.Br, B 10.D2, and (C.K × C)F1 Con A blasts. Spontaneous 
release was  17-23% with no detectable lysis of (C.K ×  C)F1 targets above 
background. 
:~ Data for an effector to target ratio of 50:1. 
§ Ratio of activity on B10.Br to B10.D2 targets, calculated from a full titration 
of responders  against a constant number of targets. 
CTL  precursors  or by  inactivation  of helper  cells required  for  the  induction  of the 
CTL  response.  To explain our data,  however, such helper cells would be required  to 
recognize  the A' cells themselves  and  would  have  to  be able  to  distinguish  F1  CTL 
specific for A' from those specific for H-2  B cells bearing foreign minor H  antigens  (B'). 
We feel the existence of such cells is unlikely,  and  therefore  favor the  interpretation 
that  A' T  cells can  inactivate  anti-A' CTL  and/or  their precursors  in  vivo.  Several 
hypotheses  that  can  account  for the  antigen-induced  haplotype-specific  suppression 
of CTL  induction  we have reported are listed below. 
(a)  A  fraction  of B10.Br  T  cells bears  anti-idiotype  receptors  specific  for  (C.K  × 
C)F1  CTL  receptors  that  recognize H-2k-plus-B10  minor  H  antigens,  and  not  H-2  a- 
plus-B10  minors  H  antigens  nor  H-2k-plus-unrelated  antigens.  This  population  of 
B 10.Br T  cells would be capable of inactivating recipient CTL  bearing the appropriate 
receptors.  This  T  cell-mediated  immune  response  is,  in  principle,  similar  to  that 
described  in  rats  by  Bell~rau  and  Wilson  (18).  We  feel  it  is  unlikely  that  2  ×  107 150  SUPPRESSION OF CYTOTOXIC T  CELL INDUCTION 
spleen cells would include enough of these hypothetical anti-idiotype-bearing T  cells 
to suppress the CTL reactivity of an entire animal. Furthermore, it seems likely that 
priming a  B10.Br mouse to immunocompetent C.K spleen cells would augment  the 
number of B10.Br  cells expressing such  anti-(anti-H-2k-plus-B10 minors)  receptors. 
However, the  ability  of primed  cells  to  suppress  a  CTL  response  is  not  enhanced 
compared with that of unprimed  cells  (data not  shown).  This type of anti-idiotype 
interpretation  is, however, favored by Katz et al.  (19)  as an explanation  for related 
observations. 
(b) The injected spleen cells include CTL bearing receptors that recognize recipient 
alloantigens, but specifically inactivate only those CTL in close proximity, i.e., those 
CTL that themselves recognize the injected spleen cells. This model takes into account 
the  T  cell  nature  of the  depleting  cell  and  the  haplotype-specific  nature  of  the 
suppression. We find this hypothesis highly unlikely, because cells wholly tolerant to 
host  antigens  are  quite  competent  at  depleting  a  CTL  response  (Table  IIl).  It  is 
therefore  doubtful  that  immune  recognition  of the  recipient  cells  by  the  injected 
spleen cells is required to elicit suppression. In contrast to our system, a graft vs. host 
reaction by parental (not minor H-different) spleen cells injected into F1 mice initiates 
the long-term generalized  immunosuppression of the CTL response as documented 
by Shearer and  Polisson  (20,  21).  In this  system, cocuhuring  of cells  from injected 
mice with cells from normal F1 animals resulted  in generalized suppression of CTL 
responsiveness  (21,  22).  Our  observations  clearly  contrast  with  those  of  Shearer, 
leading us to reject graft vs. host reaction as an explanation  for the haplotype- and 
antigen-specific suppressionof CTL response we have studied. 
(c)  Another  hypothesis would  predict  that  suppression  is mediated  by minor-H- 
specific suppressor T  cells of recipient origin. There is certainly a  precedent for both 
in vivo (23) and in vitro generated suppression in minor H  antigen responses (24-26). 
That tolerant spleen cells can suppress suggests that the induction of this suppression 
must be solely dependent  on the host responding to the injected cells. The types of 
suppression mechanisms that can be envisaged are limited by the lack of detectable, 
ongoing suppression  in  vitro  (21,  22)  and the short  lifespan of the phenomenon  in 
vivo. Furthermore, this suppression must be haplotype specific and must be induced 
only by the injected ceils themselves, not by F1 host cells presenting the foreign minor 
antigens. 
(d) According to a  fourth model, the injected spleen cell populations contain veto 
cells that can inactivate CTL that recognize some component of the veto cell surface. 
Here the recognition is one way: recipient CTL recognize the suppressor. It could be 
hypothesized  that  such  veto  cells  are  responsible  for  monitoring  and  eliminating 
autoreactive cells in normal mice. In in vitro experiments, Miller et al.  (27-29)  have 
presented evidence for the presence of such cells in normal thymus and bone marrow 
and in the  nude  mouse spleen.  However, these  veto cells demonstrable  in  vitro are 
specifically absent  from  unmanipulated  normal  spleens,  which  are  clearly  a  good 
source for our suppressors.  In addition,  we have found  that  bone marrow cells  are 
unable to deplete CTL activity in vivo, and high doses of thymocytes are required to 
reduce the appropriate CTL response (data not shown). The organ specificity and the 
absence of in vitro activity of the cells involved in the suppression we have observed 
make it unlikely that our depletion is mediated by the same sorts of cells described by 
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generated by in vitro culture of normal spleen cells and assayed by antigen-specific 
suppression of anti-minor H  CTL induction during MLC.  2 These spleen cell-derived 
veto cells could be suppressor cells specific for all types of antigens, but which suppress 
those minor-H-specific CTL or helper cells that recognize the veto cell itself. Again, 
the recognition is one way, but this modification of the veto cell model eliminates the 
necessity of inventing a novel spleen cell type. In our system, even Lyt-2-negative cells 
suppress, although less efficiently than Lyt-2-positive cells. This Lyt phenotype does 
not necessarily eliminate the donor cells as a potential source of suppressors (26). The 
basic  concept  of a  T  cell  that  inactivates  all  CTL  precursors  that  recognize  it 
adequately explains our findings, and perhaps the differences between our results and 
those  previously  reporting  veto  cell  activity  result  from  experimental  design.  In 
addition, we have found that long-term tolerance to subsequent syngeneic male skin 
grafts can be induced in neonatal females by injection of male T  cells, but not B cells 
(I.  L.  Weissman,  A.  Greenspan,  and  L. Jerabek,  manuscipt  in preparation). These 
results are consistent with a model of "one way" depletion or suppression of host cells 
recognizing antigenic donor T  cells. 
(e)  The final hypothesis that we believe can explain our results suggests that  the 
injected spleen cells eliminate the CTL response passively by temporarily inactivating, 
sequestering, or altering the  transferability of the responding CTL precursors.  For 
example, antigens injected intravenously tend to localize in the spleen and selectively 
recruit lymphocytes to this organ  (30).  Perhaps when spleen cells are injected and 
migrate  to  the  recipient  lymphoid  organs,  recipient cells  interacting directly with 
these injected spleen cells are trapped, or rendered sensitive to mechanical manipu- 
lations, or become unresponsive to the proper activation signals. Thy-l-positive cells 
of any Lyt phenotype might  be expected to interact with CTL efficiently, because 
they migrate to the T  cell-rich regions of the host lymphoid tissues (31, 32). In fact, 
recent in vivo experiments show that T  cells are particularly efficient at presenting 
antigen to CTL precursors in draining lymph nodes (33). The "sequestration" theory 
predicts that minor-H antigen-bearing tolerant cells would be capable of depletion 
and predicts that suppression would be temporary. However, our experiments show 
that direct-primed activity could not be recovered in cultured splenic fragments, and 
both intraperitoneal and intravenous injection of minor H-different spleen cells result 
in depletion (data not shown). In fact, an intact recipient spleen is not required for 
depletion: direct-primed CTL activity is equally depleted in lymph node responders 
from  splenectomized  and  from  normal  mice  (Table  IV).  Thus,  there  is  nothing 
peculiar about the splenic architecture that is a required component in depletion. If 
CTL precursors are  trapped by virtue of recognizing the injected spleen cells, this 
sequestration can take place outside the spleen. These results contrast with those of 
Streilein and  Niederkorn  (34)  who find a  strong splenic dependence of the loss of 
immune response to H-2-compatible tumors introduced in the anterior chamber of 
the eye of unprimed mice. 
There are previous observations reported by Sprent and Miller (35)  of temporary 
unresponsiveness on the  part  of spleen,  lymph node,  and  Peyer's patch  cells  from 
animals recently injected with a high dose of heterologous erythrocytes. This antigen- 
2 Rammensee, H.-G., Z. A. Nagy,  and J. Klein. Suppression  of cell-mediated lymphocytotoxicity  against 
minor histocompatibility  antigens mediated by Lyt-1  +, Lyt-2  + T cells of stimulator-strain origin. Manu- 
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specific  unresponsiveness  was  explained  as  a  direct  result  of  antigen  activation, 
perhaps reflecting a  transient high-zone tolerance. These authors were unable, as are 
we, to define and characterize the mechanisms involved. 
Several  elegant  in  vitro systems have been  devised to  investigate which  cells are 
competent to present antigen to CTL and the events accompanying this presentation. 
The relative simplicity of these systems allows the investigator to manipulate impor- 
tant  parameters, yet at  the same time they cannot  take into  account  the  details of 
lymphoid organ architecture and antigen and cell trafficking that determine the types 
of cells that  can  interact  in  vivo and  thereby  influence  the  nature  of the  immune 
response. Our studies indicate that the in vivo presentation of minor H  antigens by T 
cells can profoundly suppress the response of recipient CTL. Understanding this short- 
lived  suppression,  which  may result  from inactivation  or sequestration  of antigen- 
reactive  cells  early  in  an  immune  response,  may  influence  considerations  of the 
rejection of tumor cells and foreign tissue grafts. 
SLlmmaFy 
To detect a strong cytotoxic T  lymphocyte (CTL) response to minor histocompat- 
ibility  (H)  antigens  in  a  5-d  mixed  lymphocyte  culture,  it  is  necessary  to  use  a 
responder that has been primed in vivo with antigen-bearing cells. It has previously 
been shown that minor-H-specific CTL can be primed in vivo both directly by foreign 
spleen  cells  and  by  presentation  of  foreign  minor  H  antigens  on  host  antigen- 
presenting cells.  This latter route is evident  in the phenomenon of cross-priming, in 
which  H-2  heterozygous  (A  ×  B)F1  mice  injected  2  wk  previously with  minor  H- 
different  H-2  A (A')  spleen  cells  generate  both  H-2  A-  and  H-2B-restricted  minor-H- 
specific CTL. 
In a study of the kinetics of direct- vs. cross-priming to minors in F1 mice, we have 
found that minor H-different T  cells actually suppress the induction  of virgin CTL 
capable  of recognizing  them.  CTL  activity  measured  from  F,  mice  3-6  d  after 
injection  with  viable A' spleen  cells  is  largely H-2  B restricted.  The  H-2A-restricted 
response recovers such that roughly equal A- and B-restricted activity is detected  in 
mice as early as 8-10 d  postinjection.  This temporary hyporeactivity does not result 
from generalized immunosuppression--it is specific for those CTL that recognize the 
foreign  minor H  antigen  in  the context  of the  H-2 antigens  on the  injected  spleen 
cells.  The injected spleen cells that mediate this suppression are radiosensitive T  cells; 
Lyt-2  + T  cells are highly efficient at suppressing the induction  of CTL in  vivo. No 
graft vs. host reaction by the injected T  cells appears to be required, as suppression of 
direct primed CTL can be mediated by spleen cells that are wholly tolerant of both 
host  H-2  and  minor  H  antigens.  Suppression  cannot  be demonstrated  by in  vitro 
mixing experiments.  Several possible mechanisms for haplotype-specific suppression 
are  discussed,  including  inactivation  of responding  CTL by veto cells  and  in  vivo 
sequestration of responding CTL by the injected spleen cells. 
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